查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519736

2024-2032 年按类型、配销通路、应用和地区分類的透皮皮肤贴片市场报告

Transdermal Skin Patches Market Report by Type, Distribution Channel, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球透皮皮肤贴片市场规模达79亿美元。

透皮皮肤贴片是指一种非侵入性且易于使用的药物传递方法，可在预定时间内将恆定且一致的治疗剂量注入血液中。它们由背衬、药物、薄膜、黏合剂、衬垫、化学增强剂和渗透剂、物理辅助设备以及离子电渗疗法等低电流组成。它们提供一致的扩散速率，取决于皮肤的特性和贴片的设计。如今，它们在世界各地被广泛用作化妆品、外用和透皮给药系统。

透皮皮肤贴片市场趋势：

透皮皮肤贴片可有效治疗心臟和荷尔蒙失调、偏头痛、帕金森氏症、阿兹海默症、中风、人类免疫缺陷病毒 (HIV)、骨质疏鬆症和不宁腿症候群。因此，患有这些疾病的人口比例的显着增加是推动市场成长的关键因素之一。此外，这些贴剂有助于避免传统的口服药物摄取途径，减少静脉或肠胃外治疗造成的不便，并预防胃肠道毒性、噁心和呕吐。此外，由于给药方便，透皮皮肤贴片越来越受到关注，以提高患者在长期治疗慢性疼痛和戒烟治疗期间的依从性。除此之外，以可负担的成本获得更好的治疗方法的需求不断增加，加上不同药物类别的临床试验数量显着增加，正在对市场产生积极影响。此外，压敏胶合剂和渗透促进剂的引入可增加产品扩散并增强药物保留能力，预计将为市场参与者提供有利可图的机会，并在未来几年扩大透皮皮肤贴片在全球的应用。

本报告回答的关键问题

  • 2023年全球透皮皮肤贴片市场规模有多大？
  • 2024-2032年全球透皮皮肤贴片市场的预期成长率为何？
  • 推动全球透皮皮肤贴片市场的关键因素是什么？
  • COVID-19 对全球透皮皮肤贴片市场有何影响？
  • 根据类型，全球透皮皮肤贴片市场的细分如何？
  • 根据应用，全球透皮皮肤贴片市场的细分如何？
  • 全球透皮贴片市场的关键区域有哪些？
  • 全球透皮皮肤贴片市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球透皮皮肤贴片市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 单层药物黏合剂
    • 市场走向
    • 市场预测
  • 多层药物黏合剂
    • 市场走向
    • 市场预测
  • 矩阵
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网上商店
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 缓解疼痛
    • 市场走向
    • 市场预测
  • 减少吸烟和戒烟援助
    • 市场走向
    • 市场预测
  • 膀胱过动症
    • 市场走向
    • 市场预测
  • 荷尔蒙疗法
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
    • tesa SE (Beiersdorf AG)
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112024A5142

The global transdermal skin patches market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, distribution channel and application.

Breakup by Type:

Single-layer Drug-in-Adhesive

Multi-layer Drug-in-Adhesive

Matrix

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by Application:

Pain Relief

Smoking Reduction and Cessation Aid

Overactive Bladder

Hormonal Therapy

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global transdermal skin patches market in 2023?
  • 2. What is the expected growth rate of the global transdermal skin patches market during 2024-2032?
  • 3. What are the key factors driving the global transdermal skin patches market?
  • 4. What has been the impact of COVID-19 on the global transdermal skin patches market?
  • 5. What is the breakup of the global transdermal skin patches market based on the type?
  • 6. What is the breakup of the global transdermal skin patches market based on the application?
  • 7. What are the key regions in the global transdermal skin patches market?
  • 8. Who are the key players/companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players